224 related articles for article (PubMed ID: 32194659)
1. Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers.
Zhao SF; Yin XJ; Zhao WJ; Liu LC; Wang ZP
Oncol Lett; 2020 Mar; 19(3):1673-1682. PubMed ID: 32194659
[TBL] [Abstract][Full Text] [Related]
2. Expression and the Prognostic Value of Biglycan in Gastric Cancer.
Hu S; Li P; Wang C; Liu X
Comput Math Methods Med; 2022; 2022():2656480. PubMed ID: 36110576
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.
Schulz GB; Grimm T; Sers C; Riemer P; Elmasry M; Kirchner T; Stief CG; Karl A; Horst D
Urol Oncol; 2019 Aug; 37(8):530.e9-530.e18. PubMed ID: 31176613
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma.
Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X
Gene; 2022 Jun; 827():146461. PubMed ID: 35358652
[TBL] [Abstract][Full Text] [Related]
5. High expression of biglycan is associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Zhu YH; Yang F; Zhang SS; Zeng TT; Xie X; Guan XY
Int J Clin Exp Pathol; 2013; 6(11):2497-505. PubMed ID: 24228112
[TBL] [Abstract][Full Text] [Related]
6. The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness.
Pinto F; Santos-Ferreira L; Pinto MT; Gomes C; Reis CA
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33809543
[TBL] [Abstract][Full Text] [Related]
7. Relationship of biglycan and decorin expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma.
Liu M; Wang W; Piao S; Shen Y; Li Z; Ding W; Li J; Saiyin W
J Oral Pathol Med; 2023 Jan; 52(1):20-28. PubMed ID: 36308714
[TBL] [Abstract][Full Text] [Related]
8. Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer.
Morimoto H; Hida Y; Maishi N; Nishihara H; Hatanaka Y; Li C; Matsuno Y; Nakamura T; Hirano S; Hida K
Thorac Cancer; 2021 May; 12(9):1347-1357. PubMed ID: 33709550
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of the extracellular matrix component Biglycan regulated by Hedgehog signalling promotes colorectal cancer cell proliferation.
Zeng S; Zhou F; Wang Y; Zhai Z; Xu L; Wang H; Chen X; Luo S; Cheng M
Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(2):243-251. PubMed ID: 35130618
[TBL] [Abstract][Full Text] [Related]
10. Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.
Vaxevanis CK; Bauer M; Subbarayan K; Friedrich M; Massa C; Biehl K; Al-Ali HK; Wickenhauser C; Seliger B
Oncoimmunology; 2023; 12(1):2152998. PubMed ID: 36531688
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
Jacobsen F; Kraft J; Schroeder C; Hube-Magg C; Kluth M; Lang DS; Simon R; Sauter G; Izbicki JR; Clauditz TS; Luebke AM; Hinsch A; Wilczak W; Wittmer C; Büscheck F; Höflmayer D; Minner S; Tsourlakis MC; Huland H; Graefen M; Budäus L; Thederan I; Salomon G; Schlomm T; Melling N
Neoplasia; 2017 Sep; 19(9):707-715. PubMed ID: 28830008
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Biglycan as Prognosis and Therapy Markers for Patients with Stomach Adenocarcinoma.
Shao C; Cheng C; Shao Q; Chen B
Int J Gen Med; 2021; 14():3497-3509. PubMed ID: 34295178
[TBL] [Abstract][Full Text] [Related]
13. BGN May be a Potential Prognostic Biomarker and Associated With Immune Cell Enrichment of Gastric Cancer.
Zhang S; Yang H; Xiang X; Liu L; Huang H; Tang G
Front Genet; 2022; 13():765569. PubMed ID: 35154268
[No Abstract] [Full Text] [Related]
14. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
15. Biglycan as a potential regulator of tumorgenicity and immunogenicity in K-RAS-transformed cells.
Subbarayan K; Massa C; Leisz S; Steven A; Bethmann D; Biehl K; Wickenhauser C; Seliger B
Oncoimmunology; 2022; 11(1):2069214. PubMed ID: 35529675
[TBL] [Abstract][Full Text] [Related]
16. Dissecting the role of cancer-associated fibroblast-derived biglycan as a potential therapeutic target in immunotherapy resistance: A tumor bulk and single-cell transcriptomic study.
Zheng S; Liang JY; Tang Y; Xie J; Zou Y; Yang A; Shao N; Kuang X; Ji F; Liu X; Tian W; Xiao W; Lin Y
Clin Transl Med; 2023 Feb; 13(2):e1189. PubMed ID: 36772945
[TBL] [Abstract][Full Text] [Related]
17. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
[No Abstract] [Full Text] [Related]
18. The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3.
Zhang X; Lee SJ; Young MF; Wang MM
Transl Stroke Res; 2015 Apr; 6(2):148-55. PubMed ID: 25578324
[TBL] [Abstract][Full Text] [Related]
19. Biglycan promotes hepatic fibrosis through activating heat shock protein 47.
Yu M; He X; Song X; Gao J; Pan J; Zhou T; Wang Q; Zhu W; Ma H; Zeng H; Xu C; Yu C
Liver Int; 2023 Feb; 43(2):500-512. PubMed ID: 36371672
[TBL] [Abstract][Full Text] [Related]
20. Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.
Thiesen AP; Mielczarski B; Savaris RF
PLoS One; 2023; 18(3):e0282176. PubMed ID: 36972253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
